Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age: A Case-Control Study

NCT06856967 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.

NCT NCT06856967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age: A Case-Control Study
Lead sponsor
Meyer Children's Hospital IRCCS
Phase
Observational
Overall status
Recruiting
Start date
December 4, 2024
Completion date
April 30, 2025
Enrollment
138 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory synctial virus infections